New hope for spinal cord injury patients

August 29, 2012, Monash University
New hope for spinal cord injury patients

A new antibody could reverse the damage caused by trauma to the central nervous system, according to new research.

After a neurotrauma event, such as a spinal cord injury, the body produces an inflammatory response that often leads to scarring and permanent nerve damage. There are currently no treatment options.

Research published in The and led by Monash University's Australian Institute (ARMI)  and the Centre for Eye Research Australia (CERA) details how a new antibody, created by the US therapeutic antibody company Lpath, blocks the effects of lysophosphatidic acid (LPA). A molecule released in response to injury, LPA promotes inflammation and nerve cell death.

The research team, led by Dr Yona Goldshmit of ARMI and Dr Alice Pébay of CERA, demonstrated that by administering the antibody soon after the injury occurred, it was possible to preserve and limit the amount of scarring, while substantially reducing the losses in motor function.

Dr Goldshmit said the study reinforced earlier research on the role of LPA after an injury.

"By blocking the effects of LPA, we can help nerve cells survive a traumatic injury and this will hopefully lead to better outcomes for patients in the future," Dr Goldshmit said.

Dr Pébay, Head of CERA's Neuroregeneration Unit, said the study offered great hope for a future pharmacological therapy for in humans.

"Perhaps this drug will one day be administered in the back of an ambulance, as the patient is being transported to hospital," Dr Pébay said.  

The research has been funded by the Transport Accident Commission (TAC) and the National Health and Medical Research Council (NHMRC).

The TAC's CEO Janet Dore said that each year on average, the TAC accepted 25 new claims for people with injuries, both quadriplegia and paraplegia.

"These people will need rehabilitation and medical support from the TAC across their lifetime. Research like this gives us hope that many traumatic spinal injuries could be avoided in the future," Ms Amies said.

Explore further: Zebrafish reveal promising mechanism for healing spinal cord injury

More information: www.sciencedirect.com/science/ … ii/S0002944012004440

Related Stories

Zebrafish reveal promising mechanism for healing spinal cord injury

July 6, 2012
Scientists in Australia are studying the mechanisms of spinal cord repair in zebrafish, which unlike humans and other mammals can regenerate their spinal cord following injury. Their findings suggest a family of molecules ...

Spinal cord treatment offers hope

November 18, 2011
Queensland University of Technology (QUT) researchers have developed a promising new treatment for spinal cord injury in animals, which could eventually prevent paralysis in thousands of people worldwide every year.

Fish study raises hope for spinal injury repair

May 30, 2012
(Medical Xpress) -- Scientists have unlocked the secrets of the zebra fish’s ability to heal its spinal cord after injury, in research that could deliver therapy for paraplegics and quadriplegics in the future.

Research offers hope in new treatment for spinal cord injuries

May 3, 2011
Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain.

Evidence for spinal membrane as a source of stem cells may advance spinal cord treatment

October 28, 2011
Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential ...

Recommended for you

Nanoparticle vaccine offers universal protection against influenza A viruses, study finds

January 24, 2018
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia ...

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.